Yahoo Web Search

Search results

1. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 16 hours ago

     Live from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire ...

2. • 

     Thousands to get cutting-edge personalised cancer vaccines in NHS trials

     Daily Express· 5 days ago

     A cancer vaccine revolution will see thousands of NHS patients receive cutting-edge treatments...

3. • 

     Understanding the importance of sunscreen in the Black community

     Pittsburgh Tribune-Review· 1 day ago

     Like many Black men and women, Jessica Pearson didn’t learn about sunscreen growing up. It wasn’t...

4. • First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related...

     Forrest City Times-Herald· 4 days ago

     Johnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in patients with locally advanced or metastatic ...

5. • ...Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its...

     Benzinga· 3 days ago

     Study shows that FPM data can be reliably and quickly generated even through minimally invasive small-needle biopsies, which may expand the accessibility of FPM to provide personalized treatment validation and

6. • Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are...

     ThePress.net· 3 days ago

     Data were reported from 173 patients with advanced ROS1-positive non-small cell lung cancer (NSCLC) who were treated with taletrectinib.

7. • RYBREVANT® (amivantamab-vmjw) plus lazertinib is the only chemotherapy-free regimen showing longer...

     Forrest City Times-Herald· 4 days ago

     Results from the new analysis show the RYBREVANT® combination consistently and significantly improved progression-free survival (PFS) compared to osimertinib in patients with ...

8. • 

     Skin Cancer

     KKCO Grand Junction CO· 6 days ago

     To learn more about Intermountain Health Care, visit intermountainhealthcare.org/locations/intermountain-health-st-marys-regional-hospital. Basking in...

9. • 

     Medical Moonshots: 3 Biotech Stocks Set to Skyrocket

     InvestorPlace· 5 days ago

     Thanks to biotech companies that produce transformative drugs and treatments, we now have the collective ability to combat diseases that used to bring...

10. • 

      New US liver transplant policy raises cost and equity concerns, according to new study

      WPBF West Palm Beach· 6 days ago

      Changes to the policy that governs how liver transplants are allocated in the United States were...